Hansson U, Toksvig-Larsen S, Ryd L, Aspenberg P
Once-weekly oral medication with alendronate does not prevent migration of knee prostheses: A double-blind randomized RSA study. [Journal Article]
Acta Orthop 2009 Feb; 80(1):41-5.
BACKGROUND AND PURPOSE: Early migration of joint replacements is an effect of poor fixation and can predict late loosening. By reducing the bone resorption after implantation of a joint replacement, it should be possible to enhance the initial fixation of the implant. We studied the effect of once-weekly treatment with alendronate after knee replacement.
PATIENTS AND METHODS: We recruited 60 patients (60 knees) with gonarthrosis who were scheduled for a total knee replacement. They were operated on with identical implants and uncemented fixation. 30 patients were treated with a bisphosphonate (alendronate) and 30 patients underwent placebo treatment. The treatment started postoperatively and continued on a weekly basis for 6 months. The fixation of the implants was measured with repeated radiostereometry for 2 years.
RESULTS: There was no difference in migration of implants between the two groups.
CONCLUSION: With uncemented fixation of knee implants, no benefit of once-weekly treatment with alendronate, starting postoperatively, could be seen during a 2-year follow-up period.
More from this journal |
